Malcolm Gregory 4
Research Summary
AI-generated summary
Colgate (CL) EVP & Controller Malcolm Gregory Exercises Options, Sells Shares
What Happened
- Malcolm Gregory, EVP and Controller of Colgate-Palmolive Co. (CL), exercised 12,747 stock options and immediately sold the same 12,747 shares on Feb 6, 2026. The options were exercised at a weighted price of $76.41 (total exercise cost reported as $973,998) and the shares were sold in the open market at a weighted average price of $94.91 for total gross sale proceeds of $1,209,822. This is a cashless exercise/sale (exercise followed by an immediate sale), which is typically a routine liquidity/compensation event rather than an overt bullish purchase.
Key Details
- Transaction date: 2026-02-06.
- Option exercise: 12,747 shares at $76.41 per share = $973,998 (footnote F1: options under issuer's incentive plan).
- Sale: 12,747 shares sold at a weighted average price $94.79–$95.01 (reported weighted avg $94.91) = $1,209,822 (footnote F3 explains the price range).
- Cashless handling: A portion of the sale proceeds was delivered to the issuer to cover the exercise price and related tax withholding (footnote F2).
- Reported a separate derivative disposal line at $0 consistent with the conversion/exercise of the option (Form 4 reporting detail).
- Vesting note: Options vested in one‑third increments beginning on the first anniversary of the Sept 10, 2020 grant date (footnote F4).
- Shares owned after the transaction: not specified in the data provided in this summary; see the Form 4 for the insider’s post-transaction holdings.
- Filing timeliness: filing date 2026-02-10 for a 2026-02-06 transaction (check the Form 4 for any tardiness notation).
Context
- This was an exercise of previously granted options followed by an immediate sale (a common cashless exercise to cover costs and taxes). Such transactions are usually routine compensation-related actions rather than a direct signal of the insider’s view on the company’s near-term stock performance.
- For deeper detail (exact per-trade prices, post-transaction holdings, or any 10b5-1 plan notes), retail investors should review the complete Form 4 filing (Accession 0001225208-26-001593).